This National Strategy for Modernizing the Regulatory System for Biotechnology Products (Strategy) sets forth a vision and goals for ensuring that the Federal regulatory system is prepared to efficiently assess the risks, if any, of the future products of biotechnology while supporting innovation, protecting health and the environment, promoting public confidence in the regulatory process, increasing transparency and predictability, and reducing unnecessary costs and burdens.
More information about modernizing the regulatory system for biotechnology products.
You will need Adobe Reader to view some of the files on this page. See EPA’s About PDF page to learn more.